₹ (%)
- NSE
- BSE
Overview
- BSE Code 509470
- NSE Symbol
- ISIN Demat INE01TL01014
- Book Value (₹) 32,204.87
- Face Value (₹) 100.00
- Market Cap (₹ Cr.) 364.29
- P/E (TTM) 21.28
- EPS (TTM) 1,141.27
- Div Yield (%) 0.14
Performance
Corporate Actions
No Data Found
About Bombay Oxygen Investments Ltd
Bombay Oxygen Corporation (BOCL) was formally created and deployed as a legal entity in 1960 to manufacture and market industrial gases. Shyam M Ruia is the chairman of the company. The company's manufacturing facilities are located in Nagpur, Tarapur, Pune, Nira, Khopoli, Kalwe and Mulund, all in Maharashtra.
BOCL has a collaboration with General Electrodes and Equipments, Germany. The company has also broadened its footprint operations into into an agreement for procuring engineering services from Messer AGS Gmbh. In Mar.'95, it installed a capacity of 2.37 lac cu mtr for the manufacture of oxygen. The company manufactures various industrial gases such as oxygen, nitrogen, argon, compressed air, acetylene and medicinal oxygen. Its subsidiaries -- Savita Pharmaceuticals and Raptakos Brett & Company -- are engaged in the manufacture and distribution of pharmaceuticals.
The company has designed and successfully engineered an indigenous cryogenic liquid oxygen pump for high-pressure gas-filling purposes.
In 1996, the company has dis-invested in the shares of Raptakos Brett & Co. Therefore, Raptakos Brett & Co as also its subsidiaries, Raptakos Brett Test Laboratries and Sattva Pharmaceuticals ceased to be the company's subsidiaries.
The company is also implementing new large tonnage Oxygen plant of 130 TPD at Kalwe, the same is expected to go on stream in 1999.
Founded | : 1960 |
Chairman | : Shyam M Ruia |
Address | : 22/B Mittal Tower, 210 Nariman Point, Mumbai, Maharashtra, 400021, |
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)